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Abstract: The biochemical mechanisms mediating the rapid distribution of valproic acid across 
placenta are not precisely known. We have characterized valproic acid transport by the human 
trophoblast using the human choriocarcinoma cell line, BeWo.  The uptake of [14C]valproic acid 
by BeWo cells was found to be saturable and blocked by pre-exposure to the metabolic 
inhibitors, sodium azide and 2,4-dinitrophenol.  Valproic acid uptake by the BeWo cells was also 
inhibited by the protonophore, carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) but 
not anion exhange inhibitor.  Selected monocarboxylic acids inhibited the uptake of [14C]valproic 
acid by BeWo cells, whereas dicarboxylic acids did not alter the uptake process. Analysis of 
Lineweaver-Burk plots of valproic acid uptake in the presence of benzoic acid, a marker for the 
monocarboxylic acid transporter, revealed a competitive process for uptake.  In transcellular 
transport experiments, the permeation of [14C]valproic acid from the apical-to-basal side of the 
monolayers was signficantly greater than the permeation from basal-to-apical side.  Additionally, 
the permeation of [14C]valproic acid from apical-to-basal side was inhibited by monocarboxylic 
acids and not dicarboxylic acids.  The results provide biochemical evidence of a proton-
dependent, saturable, and asymmetric transport system, presumed to be a monocarboxylic acid 
transporter, for valproic acid in a human trophoblast model. 
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1. Introduction 
 The antiepileptic drug valproic acid readily crosses the placenta and use of the 
drug in pregnancy is associated with increased fetal malformation and potential toxicity 
(Barzago et al., 1996).   In many instances, valproic acid accumulates in higher 
concentrations in the fetal blood (Dickinson et al., 1979; Ishizaki et al., 1981; Nau et al., 
1982;1984). The biochemical mechanisms mediating the rapid and  disproportionate 
amount of valproic acid distribution across the placenta are not fully understood.  
Explanations have included observations that with the progression of pregnancy a pH 
gradient develops across the placental barrier that influences the distribution of weak 
acids, including valproic acid, and weak bases across the placenta (Nau and Scott, 
1986).   Maternal levels of fatty acids also rise in the circulation in pregnancy, displacing 
protein-bound valproic acid which is then available for transfer across the placental 
barrier (Nau et al., 1984; Nau, 1986) to a milieu with an increased availability of protein 
binding in the fetal serum (Froesher et al., 1984).   Finally, based on comparisons with 
more polar metabolites, it has been suggested that valproic acid transfer across the 
placenta is correlated with lipophilicity which facilitates diffusion across the trophoblast 
interface (Fowler et al., 1989).  Therefore, the transfer of valproic acid across the 
placenta has been attributed to multiple factors. 
 Valproic acid has been shown to be a substrate for monocarboxylic acid 
transporters (MCTs) in the gastrointestinal epithelium (Tsuji et al., 1994; Tamai et al., 
1995;1997) and specifically by the MCT1 isoform (Tamai et al., 1995).   Along with the 
considerations of pH, protein binding, and lipophilicity considerations, the existence of 
carrier mechanisms could play an important role determining the distribution of drugs 
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and drugs of abuse across the placental barrier (Ganapathy et al., 1999).   The mRNAs 
for five of at least seven putative MCTs have been recently identified in the human 
placenta (Price et al., 1998).  In the absence of specific inhibitors, the functional 
significance of individual MCT isoforms in the placenta has not been established.   
However, past studies with brush border membrane preparations from human 
trophoblasts (Balkovetz et al., 1988) and with the perfused human placental lobe 
(Carstensen et al., 1983) have revealed proton-dependent, carrier-mediated lactate 
transport that is presumed to be due to a MCT.  We have also demonstrated an 
asymmetric, proton-dependent, carrier mediated transport of benzoic acid across BeWo 
cells (Utoguchi et al., 1999), a trophoblast-like human choriocarcinoma cell line (Liu et 
al., 1997).  
We have hypothesized that valproic acid might also be transported via a MCT 
contributing to the observed distribution of valproic acid across the placental barrier.  
Therefore, to implicate or rule out the role of a MCT our objective in this study was to 
characterize the biochemical properties of valproic acid uptake and transport by the  
human trophoblast using BeWo cells.      
 
 
2. Materials and Methods 
2.1 Materials.  [14C]Valproic acid (55 Ci/mol) was obtained from American 
Radiolabeled Chemicals (St. Louis, MO).  Fetal bovine serum (FBS) was from JRH 
Bioscience (Lenexa, KS).  Penicillin-streptomycin as a mixture was from Gibco 
(Gaithersburg, MD).  Translucent polycarbonate filters (13 mm diameter, 0.4 µm pore 
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size) were purchased from Fisher Scientific.  All other chemicals were of the purest 
available analytical grade and purchased from Fisher or Sigma (St. Louis, MO). 
 
2.2 Cell Culture.  The BeWo cell line was originally derived from a human 
choriocarcinoma (Pattillo and Gey, 1968).  The BeWo clone (b30) was obtained from 
Dr. Alan Schwartz (Washington University, St. Louis, MO).  The cells were cultured by 
the methods previously described and generally cells used in this study were from 
passages 28 to 40 (Liu et al, 1997).  Briefly, the cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM) with 10% heat-inactivated FBS containing 0.37% 
sodium bicarbonate and 1% antibiotics (10,000 U/ml penicillin and 10 mg/ml 
streptomycin).  The cells were maintained in 175-cm2 flasks at pH 7.4 under 5% CO2 
and 95% humidity at 37°C.  The cells were harvested by exposure to a trypsin-EDTA 
solution (0.25% trypsin and 0.02% EDTA in HBSS) and passed onto 12-well tissue 
culture plates or polycarbonate membranes coated with rat tail collagen in 100-mm 
culture dishes.  With the seeding density of 10,000 cells/cm2, the cells formed 
monolayers between 2 and 3 days. 
 
2.3 Uptake Experiments.  The BeWo cells at confluence were washed twice 
with Hanks' balanced salt solution (HBSS; 136.7 mM NaCl, 0.385 mM Na2HPO4, 0.441 
mM KH2PO4, 0.952 mM CaCl2, 5.36 mM KCl, 0.812 mM MgSO4, 25 mM D-glucose and 
10 mM HEPES (2-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanesulfonic acid) for adjustment 
to pH 7.0 or 7.5 or 10 mM MES (2-morpholinoethanesulfonic acid, monohydrate) for 
adjustment to pHs <6.5 and then the test solution containing [14C]valproic acid (0.25 
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µCi/ml, 4.6 µM) was added.  The pH of the test solution was 6.0 except in the pH-
dependent uptake experiment.  After 30 s, the test solution was aspirated away and the 
cells were washed with ice-cold HBSS three times.  For quantitation of drug uptake, the 
cells were suspended in 1.0 N NaOH and the suspension was incubated at 37°C 
overnight at which point, a half volume of 2.0 N HCl was added.  Radioactivity was 
quantitated using a liquid scintillation counter.  Cellular protein was quantified using a 
protein assay kit (Pierce) with bovine serum albumin as a standard.  Additional details of 
the conditions for each experiment are provided in the Figure legends or Table 
footnotes. 
 
2.4 Transport Experiments.  A horizontal Side-Bi-Side diffusion apparatus 
(Crown Glass) was used to measure the transmonolayer permeability of cells grown on 
the surface of 0.4 µm pored polycarbonate filters, as previously described (Liu et al., 
1997).  The cells faced the donor chamber as the apical side, and the polycarbonate 
membrane faced the receiver chamber as the basal side.  The water jacket surrounding 
the donor and the receiver chambers was thermostated at 37°C.  The contents of each 
chamber were continuously stirred at 600 rpm with magnetic stir bars.  When the apical-
to-basal transport studies were performed, the pH of the donor (apical) side was 6.0 and 
that of receptor (basal) side was 7.4.  When the basal-to-apical transport studies were 
performed, the pH of the donor (basal) side was 6.0 and that of receptor (apical) side 
was 7.4.  The concentration of added [14C]valproic acid was 4.6 µM (0.25 µCi/ml).  A 
0.2-ml aliquot from the receiver chamber was taken at several time points up to 60 min. 
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2.5 Permeability Coefficient Calculations.   Apparent permeability coefficients 
for the BeWo monolayers, Pe, was calculated from the following relationship 
1/Pt = 1/Pe + 1/Pm                                             Eq. (1)  
where Pt is apparent permeability coefficient for the collagen-coated membrane in the 
presence of BeWo cell monolayers, and Pm is the apparent permeability coefficient for 
collagen-coated polycarbonate membrane alone (Adson et al., 1994). 
 
2.6 Data Analysis.  To estimate the values of the kinetic parameters of 
saturable uptake by BeWo cells, the uptake rate (J) was fitted to the following equation, 
which consists of both saturable and nonsaturable linear terms, using a nonlinear least-
squares regression analysis program MULTI (Yamaoka et al., 1981):  
J = Jmax  X  C  /   ( Kt  +  C )  +  k  X  C               Eq. (2)    
where Jmax is the maximum uptake rate for a carrier-mediated process, C is the 
valproic acid concentration, Kt is the half-saturation concentration (Michaelis constant), 
and k is a nonsaturable clearance constant.   
 
2.7 Statistical Analysis.  All results were expressed as means ± standard 
deviation (SD).  Statistical analysis between two groups was performed using Student's 
t-test, and one-way analysis of variance (ANOVA) was used for single and multiple 
comparisons.  P values of 0.05 or less were considered to indicate a statistically 
significant difference.    
 
 
3. Results 
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Time and concentration dependence of valproic acid uptake.  [14C]Valproic acid 
rapidly accumulated in BeWo cells with time as illustrated in Figure 1.  The uptake was 
linear initially and reached an equilibrium at about 2 min.  Therefore, all further uptake 
studies were performed at 30 s.   Figure 2 shows the relationship between the initial rate 
of uptake of [14C]valproic acid and its concentration in the incubation buffer.  The results 
indicated that the uptake of valproic acid consists of two processes, a saturable process 
evident at low concentrations likely mediated by a carrier mechanism and an apparent 
nonsaturable process evident at high concentrations.  The uptake processes were 
analyzed according to Eq. (2).  The kinetic parameters calculated for valproic acid 
uptake were a Jmax of 29 nmol/30 s/mg of protein, a Kt of 0.20 mM, and a k of 6.9 µl/30 
s/mg of protein.  The middle dashed line represents the uptake for the saturable 
component calculated from the kinetic parameters.  The lower dotted line represents the 
uptake for the nonsaturable component calculated from the kinetic parameters.  Over 
the concentration range examined, the uptake by saturable component is higher than 
the nonsaturable uptake. 
Cellular metabolism and pH dependence of valproic acid uptake.  The effects of 
metabolic inhibitors on the uptake of [14C]valproic acid were studied to determine 
whether this uptake requires cellular energy expenditure as summarized in Table 1.  
Both sodium azide (10 mM), a respiratory chain inhibitor, and 2,4-dinitrophenol (1 mM), 
an uncoupler of oxidative phosphorylation, dramatically inhibited the uptake of 
[14C]valproic acid by the BeWo cells.  Figure 3 illustrates the effect of incubation buffer 
pH in the range from 5.0 to 7.5 on [14C]valproic acid uptake by BeWo cells.  The rate of 
[14C]valproic acid uptake decreased with increasing pH from an acidic to a neutral pH.   
Utoguchi, N. and Audus, K.L. (2000) Carrier-mediated transport of valproic acid in BeWo cells, a human trophoblast cell line.  
Int. J.  Pharm. 195, 115-124.  PMID: 10675689.  Publisher’s official version: <http://dx.doi.org/10.1016/S0378-5173(99)00398-
1> .  Open Access version:  http://kuscholarworks.ku.edu/dspace/. 
8 
 
Moreover, carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP; 50 µM), a 
protonophore, significantly inhibited the uptake (Table 1), whereas 4,4'-
diisothiocyanostilbene-2,2'-disulfonic acid (DIDS; 0.1 mM), an anion-exchange inhibitor, 
had no inhibitory effect.   These studies were carried out with concentrations of 
inhibitors shown to be effective in other cell systems to identify the respective proton-
gradient and anion-exchange mechanisms (Tsuji et al., 1994).  These findings 
suggested that valproic acid uptake by BeWo cells is dependent on cellular energy 
expenditure and a proton gradient.     
Specificity of the valproic acid uptake mechanism.  To investigate the specificity 
of the carrier process involved in [14C]valproic acid uptake by BeWo cells, we studied 
the effects of various mono- and dicarboxylic acids on this uptake.  Results are 
presented in Table 2.  Each monocarboxylic acid tested significantly inhibited the uptake 
of [14C]valproic acid, whereas none of the dicarboxylic acids were effective inhibitors.  
These results imply that the carrier that mediates valproic acid uptake by BeWo cells is 
a nonspecific monocarboxylic acid carrier.   
To characterize the competitive nature of the mechanism mediating uptake of 
valproic acid,  we analyzed the inhibitory effect kinetically. Figure 4A shows a 
Lineweaver-Burk plot for the uptake of [14C]benzoic acid by BeWo cells in the absence 
or presence of 2 mM valproic acid.  Valproic acid competitively inhibited the uptake of 
benzoic acid by the BeWo cells.   Figure 4B shows a Lineweaver-Burk plot for the 
uptake of [14C]valproic acid by BeWo cells in the absence or presence of 2 mM benzoic 
acid.   Benzoic acid competitively inhibited the uptake of valproic acid by the BeWo 
cells. The inhibition constant for valproic acid was 1.0 mM and the inhibition constant of 
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benzoic acid was 0.8 mM and in good agreement with the BeWo cell uptake constant 
determined for valproic acid from data in Figure 2. 
Transmonolayer Transport.  The passage of [14C]valproic acid across the BeWo 
monolayer was found to be asymmetric, with the permeability coefficient greater in the 
apical-to-basal direction than that in the basal-to-apical direction, as shown in Figure 5.  
The passage of [14C]valproic acid across the BeWo monolayers from apical to basal 
side was not inhibited by a representative dicarboxylic acid (glutaric acid) but was 
inhibited by an excess amount of unlabeled valproic acid and other representative 
monocarboxylic acids (benzoic acid and acetic acid) as shown in Figure 6.   These 
findings for transmonolayer valproic acid were consistent with the apical uptake 
mechanism.  
 
 
4. Discussion   
We have characterized the BeWo cell line as an in vitro system to investigate 
some of the transport and metabolism properties of the human trophoblast (Liu et al., 
1997).  The BeWo cell line is particularly attractive for these studies because it is stable, 
relatively easy to maintain by passage, and grows to a confluent monolayer in relatively 
short period of time.  More importantly, the BeWo cell displays morphological properties 
and biochemical marker enzymes common to normal trophoblasts (Pattillo and Gey, 
1968; Liu et al., 1997; Kenagy et al., 1998) and have been shown applicable to the 
characterization of asymmetric transcellular transport of serotonin and monoamine 
uptake (Prasad et al., 1996), asymmetric amino acid transport (Furesz et al., 1993; Moe 
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et al., 1994; Way et al., 1998), asymmetric transferrin transport (Van der Ende et al., 
1990; Cerneus et al., 1993), asymmetric fatty acid transport (Liu et al., 1997), choline 
uptake (Eaton and Sooranna, 1998a), glucose modulation of arginine transport (Eaton 
and Sooranna, 1998b), and asymmetric IgG transport (Ellinger et al., 1999).   Recently, 
we have shown an asymmetric, proton-dependent transport of representative 
monocarboxylic acids, benzoic acid and acetic acid, in the BeWo cells (Utoguchi et al., 
1999).    
In this study, we have been able to establish the putative role of a MCT in carrier-
mediated transport of valproic acid in the trophoblast using the BeWo cell line.   
Valproic acid uptake (or transport) by BeWo cells was saturable at higher 
concentrations and strongly inhibited by metabolic inhibitors, properties suggestive of an 
energy dependent carrier mediated process. Although valproic acid uptake by BeWo 
cells was not inhibited in a Na+-depleted buffer,  prepared by substituting choline 
chloride for NaCl and NaH2PO4 (data not shown), valproic acid uptake was pH-
dependent and the protonophore FCCP inhibited the uptake of valproic acid. These 
results strongly suggest that valproic acid uptake was proton-gradient-dependent.    In 
addition, both valproic acid uptake and transport were significantly inhibited by 
representative monocarboxylic acids. Kinetic analysis revealed a competitive inhibition 
with a typical MCT substrate, benzoic acid (Tsuji et al., 1994; Tamai et al., 1995;1997).    
Finally, the transport of valproic acid was asymmetric, favoring predominant transport in 
the apical to basolateral direction which corresponds to maternal to fetal distribution of 
the drug.   Collectively, the transport properties of valproic acid were consistent with 
previous reports on MCT activity in intestinal epithelium (Tsuji et al., 1994; Tamai et al., 
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1995;1997), the behavior of lactate transport in trophoblast brush border membrane 
preparations (Balkovetz et al., 1988), and with our earlier work on benzoic acid uptake 
and transport by BeWo cells (Utoguchi et al., 1999).   Therefore, we propose that 
valproic acid is transported across the human trophoblast by an apparent MCT and this 
mechanism likely plays a key role in facilitating the rapid and significant distribution of 
the unbound drug into the fetal compartment.  
From previous literature, we noted that there were at least three factors 
considered important in explaining valproic acid’s rapid transfer across the placenta and 
accumulation in the fetal compartment:  the pH gradient, protein binding, and 
lipophilicity.   Our findings are not inconsistent with the role of these factors.   For 
instance, with the proton-dependent transport by an apparent MCT here is consistent 
with the observed pH-dependence of valproic acid transfer across the placenta (Nau 
and Scott, 1986).  Similarly, protein binding remains important. Valproic acid is greater 
than 90% protein bound, however, the fraction bound decreases with advancing time in 
pregnancy. It is only the non-protein bound valproic acid that is available for transfer 
across the placenta (Fowler et al., 1989).   To assess free valproic acid transport in an 
albumin-depleted condition, our studies were performed in the absence of serum.   
Although not included here, one could consider a series of experiments where serum 
levels on both sides of the BeWo monolayers are manipulated to approximate protein 
gradients present across the placenta.   We have shown in other studies that serum 
albumin does substantially reduce the transport of highly bound fatty acids across 
BeWo monolayers (Liu et al., 1997; Shi et al., 1997).   Lastly, concerning the role of 
lipophilicity, valproic acid can be metabolized to a number of more hydrophilic 
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metabolites by the liver.  Some of the representative valproic acid metabolites are 
glucuronide conjugates which have a very poor ability to permeate across the placenta.  
Because it was more lipophilic, valproic acid was proposed to cross the placenta more 
rapidly than the glucuronide metabolites (Fowler et al., 1989).    Considering the 
possible role of a MCT shown here, an alternative explanation might be the lack of 
affinity of the valproic acid-glucuronide conjugates for the carrier mechanism.  We 
should note that in the perfused human placental lobe studies (Fowler et al., 1989), 
recirculating valproic acid is not metabolized for up to six hours.   Therefore, in our 
simpler and shorter timed studies with trophoblasts, the formation of valproic acid 
metabolites was considered unlikely and would not interfere in the transport studies.  
 MCT1 appears to be the predominant isoform in tissues such as the intestine and 
has been shown to provide a mechanism for valproic acid transport (Tsuji et al., 1994; 
Tamai et al., 1995;1997).  By contrast, valproic acid uptake in the brain is believed to be 
mediated by a medium-chain fatty acid carrier (Adkison and Shen, 1996) and not a 
MCT.  While BeWo cells do possess fatty acid carriers (Liu et al., 1997; Campbell et al., 
1997), our data here clearly demonstrated that valproic acid transport can be strongly 
and competitively inhibited by monocarboxylic acids just as observed in the intestinal 
epithelium (Tamai et al., 1995).   It is possible that valproic acid can be transported 
differently depending on the tissue location or more likely, be transported by multiple 
carrier mechanisms at the placental barrier.  
Monocarboxylic acids are transported out of muscle and into liver (the so-called 
Cori cycle) by proton-coupled MCTs.  The Cori cycle is a well-known natural 
physiological process (Garcia et al., 1995).  The physiological role of a MCT in the 
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trophoblast is believed to be one of controlling the distribution of monocarboxylic acid 
metabolites across the placenta (Carstensen et al., 1983; Balkovetz et al. 1988).   
Pharmacologically, a placental MCT may be implicated in facilitating monocarboxylic 
acid drugs (e.g., valproic acid, ibuprofen, salicylate) transfer between the maternal and 
fetal compartments.   This would be in agreement with the proposed role of MCTs in 
absorption processes in the intestinal epithelium (Tsuji et al., 1994; Tamai et al., 
1995;1997; Ogihara et al., 1996).  Since, several MCT isoforms are known to exist in a 
variety of cell types (Price et al., 1998), future studies will have to include identification 
of the specific the MCT type or types associated with the placental barrier and their 
respective substrate selectivity properties to fully establish their importance in 
pharmacology.  
In summary, a putative MCT was shown to facilitate valproic acid uptake and 
transport across a human trophoblast monolayer.   MCT-mediated transport of valproic 
acid  represents an alternative mechanism that can be implicated in the observed ready 
distribution of the drug across the placental barrier.  
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Figure Legends  
Figure 1.   Time-dependent uptake of [14C]valproic acid (4.6 µM) by BeWo cell 
monolayers.  Each data point represents the mean  ±SD of four experiments.   
 
Figure  2.  Concentration-dependent uptake of [14C]valproic acid by BeWo cell 
monolayers.  The uptake of [14C]valproic acid by BeWo cells was measured at 37°C for 
30 s and is represented by the solid line through the data points.  The middle dashed 
line represents the uptake for the saturable component calculated from the kinetic 
parameters obtained as described in the text.  The lower dotted line represents the 
uptake for the nonsaturable component calculated from the kinetic parameters. Each 
data point represents the mean ± SD of four experiments.   
 
Figure 3.  The pH dependence of [14C]valproic acid (4.6 µM) uptake by BeWo cell 
monolayers.  The uptake of [14C]valproic acid by BeWo cells was measured in the 
presence of the indicated pH at 37°C.   Each point represents the mean ±SD of four 
experiments.   
 
Figure 4.    Lineweaver-Burk plots for the uptake of benzoic acid and  valproic acid by 
BeWo cell monolayers.   A: Benzoic acid uptake was measured in the absence (      ) or 
presence of 2 mM valproic acid (      ).  B:  Valproic acid uptake was measured in the 
absence  (       ) or presence of 2 mM benzoic acid (       ).  The vertical bar through each 
point represents the SD of four experiments. 
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Figure 5.  Permeation of [14C]valproic acid across BeWo cell monolayers from apical to 
basal side (A to B) or from basal to apical side (B to A).   Each point represents the 
mean ± SD of four experiments.  * p < 0.001 vs A to B  
 
Figure 6.  Effects of selected mono- and di-carboxylic acids on the permeation of 
[14C]valproic acid across BeWo cell monolayers from apical to basal side.  Each 
carboxylic acid was added to a final concentration of 10 mM.    Each point represents 
the mean ± SD of four experiments.    * p < 0.001 vs control ([14C]valproic acid alone).       
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